Segment Information (Tabulation of Business Segment Information Based on Current Segmentation) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Total Consolidated Revenue	$ 369,082	$ 364,281	$ 1,086,185	$ 1,021,195
Total consolidated adjusted operating income	72,968	76,208	217,640	178,042
Restructuring expense	(1,278)	(10,518)	(17,706)	(16,999)
Business acquisition and integration expense	(11,346)	(5,924)	(35,702)	(41,537)
Gain on sale of assets	13,317		13,317	0
Total consolidated operating income (loss)	59,429	32,949	128,613	30,783
Interest Expense	14,457	36,585	47,806	109,907
Other income (expense), net	3,980	(327)	3,301	2,435
Total consolidated income (loss) from continuing operations before income taxes	48,952	(3,963)	84,108	(76,689)
Total Consolidated capital expenditures	9,309	7,477	19,056	22,249
Total consolidated depreciation expense	10,157	11,341	31,618	33,471
Total consolidated intangible asset amortization expense	14,232	26,817	48,936	73,967
Chamberlain
Segment Reporting Information [Line Items]
Total Consolidated Revenue	149,737	142,550	426,538	417,310
Total consolidated adjusted operating income	39,589	38,910	99,820	85,556
Total Consolidated capital expenditures	4,002	3,255	6,920	9,869
Total consolidated depreciation expense	4,405	4,738	12,985	14,048
Walden University
Segment Reporting Information [Line Items]
Total Consolidated Revenue	132,874	139,081	395,715	348,325
Total consolidated adjusted operating income	24,628	25,843	78,181	68,796
Total Consolidated capital expenditures	1,198	1,629	2,291	4,561
Total consolidated depreciation expense	2,439	2,573	7,303	6,801
Total consolidated intangible asset amortization expense	14,232	26,817	48,936	73,967
Medical and Veterinary
Segment Reporting Information [Line Items]
Total Consolidated Revenue	86,471	82,650	263,932	255,560
Total consolidated adjusted operating income	16,893	18,140	56,506	50,157
Restructuring expense	(421)	(4,569)	(7,334)	(4,757)
Total Consolidated capital expenditures	1,277	891	2,192	2,650
Total consolidated depreciation expense	3,231	3,397	9,367	10,497
Home Office and Other
Segment Reporting Information [Line Items]
Total consolidated adjusted operating income	(8,142)	(6,685)	(16,867)	(26,467)
Restructuring expense	(804)	(1,793)	(6,380)	(5,960)
Total Consolidated capital expenditures	2,832	1,702	7,653	5,169
Total consolidated depreciation expense	82	633	1,963	2,125
Segment Reconciling Items
Segment Reporting Information [Line Items]
Deferred revenue adjustment	0	0	0	(8,561)
CEO transition costs	0	0	0	(6,195)
Restructuring expense	(1,278)	(10,518)	(17,706)	(16,999)
Business acquisition and integration expense	(11,346)	(5,924)	(35,702)	(41,537)
Gain on sale of assets	13,317	0	13,317	0
Total consolidated intangible asset amortization expense	$ 14,232	$ 26,817	$ 48,936	$ 73,967